TRIM67 and metabolic dysfunction-associated steatotic liver disease: As we found increased hepatic TRIM67 expression in obese mice, we presumed the loss function of TRIM67 would be beneficial for their livers, and also be protective against the progress of obesity-induced NAFLD.